Novartis to scale up data science under AI deal with Oxford

By Chris Lieu | Jan 18, 2019 | 12:08 AM GMT

Novartis AG (NYSE:NVS; SIX:NOVN) and the University of Oxford's Big Data Institute (BDI) will use artificial intelligence to analyze ultra large and multiple data sets from Novartis' drug development programs to identify